Skip to search formSkip to main contentSkip to account menu

indantadol

Known as: 2-((2,3-Dihydro-1H-Inden-2-yl)Amino)Acetamide, N-(2-Indanyl)glycinamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Indantadol is an oral and nonselective monoamine oxidase inhibitor and NMDA antagonist that is being developed by Vernalis plc…